Monitoring immunosuppressant levels at the point of care
Official title: Point-of-Care Multiplexed Immunosuppressant Monitoring
Funded at Electronic Biosciences, INC. · NIH-10759162 · Data updated 2026-11-12
This study is testing a new, easy-to-use device that helps people with autoimmune diseases or organ transplants check their immunosuppressant drug levels quickly and accurately, so they can get the right dose without needing big blood tests at a lab.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | August 10, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $300,000 |
| NIH project number | 1R43AI179266-01 |
| Project ID | NIH-10759162 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are undergoing immunosuppressive therapy due to autoimmune diseases or recent organ transplants.
✕Less likely to help
Patients who do not require immunosuppressive therapy or those with conditions unrelated to immune suppression may not benefit from this research.
What this research studies
This research focuses on developing a new method for monitoring immunosuppressant drug levels in patients who require long-term therapy due to autoimmune diseases or organ transplants. The approach aims to create a portable biosensor that can measure drug concentrations quickly and accurately, allowing for personalized dosing without the need for large blood draws at centralized labs. By utilizing advanced microfluidic technology and tandem mass spectrometry, the goal is to improve patient access to necessary monitoring and enhance treatment outcomes. This method could significantly reduce the logistical burdens faced by patients in managing their immunosuppressive therapy.
Why it matters
Potential benefit: If successful, this research could provide patients with a more convenient and accessible way to monitor their immunosuppressant levels, leading to better management of their treatment.
How similar studies have gone: Previous research has shown promise in developing point-of-care monitoring technologies, indicating potential for success with this novel approach.
Where this research is happening
-
Electronic Biosciences, INC.
San Diego, United States Active
Researchers
- Principal investigator: Schibel, Anna — Electronic Biosciences, INC.
- Study coordinator: Schibel, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.